No Data
No Data
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Half-Year Report - Term 77 (2024/04/01 - 2025/03/31)
Kinoden, Sekisui Chemical, etc. (additional) Rating
Upgrade - Bullish Code Stock Name Securities Company Previous After Change ----------------------------- <9009> Keisei Morgan S "Under W" "Equal W" Downgrade - Bearish Code Stock Name Securities Company Previous After Change ----------------------------- <7731> nikon corp spons
Ono Pharmaceutical Makes Strategic Business Decision to Allow Itolizumab Option to Expire
Ono Pharmaceutical: Revision of earnings forecasts and introduction of core-based performance
Ono Pharmaceutical: Interim Accounting Period Fiscal Period Ending March 2025 (April to September) Supplementary Financial Information (Consolidated IFRS)
No Data
No Data